[go: up one dir, main page]

PE99298A1 - Oligosacaridos modificados - Google Patents

Oligosacaridos modificados

Info

Publication number
PE99298A1
PE99298A1 PE1997000688A PE00068897A PE99298A1 PE 99298 A1 PE99298 A1 PE 99298A1 PE 1997000688 A PE1997000688 A PE 1997000688A PE 00068897 A PE00068897 A PE 00068897A PE 99298 A1 PE99298 A1 PE 99298A1
Authority
PE
Peru
Prior art keywords
glcnac
compounds
formula
preferred
tetrahidropirano
Prior art date
Application number
PE1997000688A
Other languages
English (en)
Inventor
Gebhard Thoma
Rolf Banteli
Willy Kinzy
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE99298A1 publication Critical patent/PE99298A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I), EN DONDE: R1 ES UN METILO EN CONFIGURACION S SUSTITUIDO POR UN CARBOXI Y OTRO SUSTITUYENTE o -CH(R4)-COOR3; R2 ES H, ALQUILO C1-C12 o ARILO C6; R3 ES H o My, EN DONDE My es METAL MONO O DIVALENTE, DE PREFERENCIA, Na o K; R4 ES DE PREFERENCIA CH2-C6H5, (CH2)2-C6H5, CICLOHEXILO, METILO, ETILO o ISOPROPILO; "Z" ES UN RADICAL DE FORMULA (IIa), (IIb) o (IIc), EN DONDE: "X" ES CO, COO, CS, C(S)O, ENTRE OTROS; RT1 ES ALQUILO C1-C12, DE PREFERENCIA ES (CH2)8-COO-CH3, (CH2)8-COONa o CH3; RT2 ES CICLOALQUILO C3-C12, HETEROCICLOALQUILO C2-C11, ARILO C6-C10 o HETEROARILO C5-C9, DE PREFERENCIA ES -3,4-(OH)2-C6H3 o -3,4-(OCH3)2-C6H3; RB5 ES AMINO PRIMARIO o AMIDO; R5 ES DE PREFERENCIA CH2OH, CH3 o COONa. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS (I), DONDE LA GALACTOSA-(GlcNAc o TETRAHIDROPIRANO) o FUCOSA-(GlcNAc o TETRAHIDROPIRANO) ESTA ENLAZADO CON LA FUCOSA o GALACTOSA RESPECTIVAMENTE. LOS COMPUESTOS DE FORMULA (I) SON DERIVADOS DEL SIALIL LEWIS (LIGANDO NATURAL DE LA E-SELECTINA EN LA ADHESION CELULAR), EN DONDE SE REEMPLAZA EL RESIDUO DEL ACIDO NEURAMINICO Y GlcNAc NATURAL POR R1 Y "Z" RESPECTIVAMENTE, POR LO QUE ACTUARIAN INHIBIENDO EL ENLACE DE E-SELECTINA, SIENDO UTILES EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS O AUTOINMUNES AGUDAS O CRONICAS, ENTRE OTRAS
PE1997000688A 1996-08-08 1997-08-07 Oligosacaridos modificados PE99298A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810526 1996-08-08
EP96810527 1996-08-08
EP96810636 1996-09-26

Publications (1)

Publication Number Publication Date
PE99298A1 true PE99298A1 (es) 1999-01-21

Family

ID=27237868

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000688A PE99298A1 (es) 1996-08-08 1997-08-07 Oligosacaridos modificados

Country Status (19)

Country Link
EP (1) EP0920437A1 (es)
JP (1) JP2000516224A (es)
KR (1) KR20000029862A (es)
CN (1) CN1227563A (es)
AR (1) AR008283A1 (es)
AU (1) AU720381B2 (es)
BR (1) BR9711117A (es)
CA (1) CA2260854A1 (es)
CO (1) CO4900075A1 (es)
CZ (1) CZ39099A3 (es)
ID (1) ID18010A (es)
IL (1) IL127908A0 (es)
NO (1) NO990497L (es)
NZ (1) NZ334048A (es)
PE (1) PE99298A1 (es)
PL (1) PL331286A1 (es)
SK (1) SK15699A3 (es)
TR (1) TR199900245T2 (es)
WO (1) WO1998006730A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
AU2745700A (en) 1999-02-01 2000-08-18 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US20040096396A1 (en) * 2002-07-03 2004-05-20 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
CA2501842C (en) 2002-10-11 2012-07-17 Yamanouchi Europe B.V. Glucose-based compounds with affinity to p-selectin
JP2007524658A (ja) * 2003-11-19 2007-08-30 グリコミメティクス, インコーポレイテッド E−およびp−セレクチンの両方のための糖模倣物アンタゴニスト
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
EP1934236B1 (en) 2005-09-02 2012-11-21 GlycoMimetics, Inc. Heterobifunctional pan-selectin inhibitors
NZ598863A (en) * 2007-02-09 2013-11-29 Glycomimetics Inc Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
AU2008336249B2 (en) 2007-12-10 2015-01-29 The University Of Queensland Treatment and prophylaxis
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
CN104039805B (zh) 2011-12-22 2016-11-16 糖模拟物有限公司 E-选择蛋白拮抗剂化合物、组合物及使用方法
PL2928476T3 (pl) 2012-12-07 2018-07-31 Glycomimetics, Inc. Związki, kompozycje i sposoby wykorzystujące antagonistów e-selektyny do mobilizacji komórek hematopoietycznych
KR102542750B1 (ko) 2014-12-03 2023-06-12 글리코미메틱스, 인크. E-셀렉틴 및 cxcr4 케모카인 수용체의 헤테로이작용성 억제제
EP3405473A1 (en) 2016-01-22 2018-11-28 GlycoMimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
WO2018068010A1 (en) 2016-10-07 2018-04-12 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
US11197877B2 (en) 2017-03-15 2021-12-14 Glycomimetics. Inc. Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
AU2018395417B2 (en) 2017-12-29 2023-07-13 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CN108299525B (zh) * 2018-01-05 2021-03-26 佛山科学技术学院 路易斯寡糖-x的合成方法
US11707474B2 (en) 2018-03-05 2023-07-25 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CN109762032A (zh) * 2019-01-16 2019-05-17 天津科技大学 一种磺酸化路易斯x三糖及其合成方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
WO1994020514A1 (en) * 1993-03-04 1994-09-15 Mect Corporation Lewis-associated compound, process for producing the same, and anti-inflammatory
EP0698031A4 (en) * 1993-05-14 1997-07-09 Cytel Corp SIALYL LEx ANALOGS AS INHIBITORS OF CELLULAR ADHESION
CN1176644A (zh) * 1994-12-28 1998-03-18 住友制药株式会社 路易斯x衍生物及其制备方法

Also Published As

Publication number Publication date
CO4900075A1 (es) 2000-03-27
NO990497D0 (no) 1999-02-03
SK15699A3 (en) 1999-07-12
NZ334048A (en) 2000-05-26
AR008283A1 (es) 1999-12-29
PL331286A1 (en) 1999-07-05
AU720381B2 (en) 2000-06-01
WO1998006730A1 (en) 1998-02-19
EP0920437A1 (en) 1999-06-09
CZ39099A3 (cs) 1999-05-12
JP2000516224A (ja) 2000-12-05
CA2260854A1 (en) 1998-02-19
BR9711117A (pt) 1999-09-08
NO990497L (no) 1999-03-24
IL127908A0 (en) 1999-11-30
KR20000029862A (ko) 2000-05-25
AU4378897A (en) 1998-03-06
TR199900245T2 (xx) 1999-05-21
CN1227563A (zh) 1999-09-01
ID18010A (id) 1998-02-19

Similar Documents

Publication Publication Date Title
PE99298A1 (es) Oligosacaridos modificados
PL306841A1 (en) Novel compounds suitable for use as sweerening agents and method of obtaining them
FI912873A0 (fi) Ny polypeptidfoerening och foerfarande foer dess framstaellning.
ES517966A0 (es) Un metodo de preparacion de un derivado de benzotiazepina.
NO942110D0 (no) Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav
EP0964837A4 (en) GLASS COMPOSITION TO AVOID THE ALKALI-PEBBLE SILICONE REACTION
GR73555B (es)
DE3372776D1 (en) 6-alpha-methyl-corticoids, their preparation and utilization
ES8606260A1 (es) Procedimiento para la obtencion de tioeteres alifaticos
ES519532A0 (es) Procedimiento de preparacion de derivados de imidazolidina.
NO950762L (no) Sulfaterte orer
GR851657B (es)
IE822391L (en) 4-acylamino-1-azaadamantanes
DE69806152D1 (de) Vitamin d3 analoga mit bis-c-20-seitenketten
SE7708901L (sv) Antracyklinetrar och forfarande for framstellning derav
ES2110454T3 (es) Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
GR851498B (es)
IL86377A (en) Polyfluorinated amino alcohols and their esters,their preparation and their use
IT8149419A0 (it) Dispositivo per migliorare l'anda mento del flusso dei gas penetranti nella camera di combustione di impianti tecnici di combustione a gas in particolare forni da coke
DE3260023D1 (en) 2-pyridyloxyacetanilides, process for their preparation and their use
JPS5781500A (en) Novel derivative of cardenolide-bis-digitoxoside, manufacture and heart failure remedy containing same
PE39099A1 (es) Pastilla para limpieza personal de glicerina con poliglucosido alquilo
ES536140A0 (es) Procedimiento para la preparacion de quinolinonas-4
NO965302L (no) Alfa-cykloalkyl, aryl og aralkylsubstituerte polyjodinerte aroyloksyforbindelser

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed